首页> 外文期刊>Biomaterials >Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters
【24h】

Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters

机译:转铁蛋白缀合的治疗性维生素E TPGS胶束可用于多西他赛和超亮金纳米团簇的靶向共递送

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this work was to develop an advanced theranostic micelles of D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS), which are conjugated with transferrin for targeted co-delivery of docetaxel (DTX) as a model drug and ultra bright gold clusters (AuNC) as a model imaging agent for simultaneous cancer imaging and therapy. The theranostic micelles with and without transferrin conjugation were prepared by the solvent casting method and characterized for their particle size, polydispersity, surface chemistry, drug encapsulation efficiency, drug loading and cellular uptake efficiency. Transferrin receptors expressing MDA-MB-231-luc breast cancer cells and NIH-3T3 fibroblast cells (control cells without transferrin receptor expression) were employed as an in vitro model to access cytotoxicity of the formulations. The overexpression of transferrin receptor on the surface of MDA-MB-231-luc cells was confirmed by flow cytometry. The biodistribution study and theranostic efficacy of the micelles were investigated by using the Xenogen IVIS (R) Spectrum imaging system, which includes AuNC based fluorescence imaging and luciferase induced bioluminescence imaging on MDA-MB-231-luc tumor bearing SCID mice. The IC50 values demonstrated that the non-targeted and targeted micelles could be 15.31 and 71.73 folds more effective than Taxotere after 24 h treatment with the MDA-MB-231-luc cells. Transferrin receptor targeted delivery of such micelles was imaged in xenograft model and showed their great advantages for real-time tumor imaging and inhibition of tumor growth. (C) 2014 Elsevier Ltd. All rights reserved.
机译:这项工作的目的是开发D-α-生育酚聚乙二醇1000琥珀酸酯(TPGS)的先进的诊断学胶束,将其与转铁蛋白偶联,以多西他赛(DTX)作为模型药物和超亮金簇的靶向共递送(AuNC)作为模型成像剂,用于同时进行癌症成像和治疗。通过溶剂流延法制备具有和不具有转铁蛋白缀合的治疗性胶束,并对其粒径,多分散性,表面化学,药物包封效率,药物载量和细胞摄取效率进行表征。表达MDA-MB-231-luc乳腺癌细胞和NIH-3T3成纤维细胞(无转铁蛋白受体表达的对照细胞)的转铁蛋白受体用作体外模型,以获取制剂的细胞毒性。流式细胞术证实了MDA-MB-231-luc细胞表面转铁蛋白受体的过表达。使用Xenogen IVIS(R)Spectrum成像系统研究了胶束的生物分布研究和治疗功效,该系统包括基于Mau-MB-231-luc荷瘤SCID小鼠的AuNC荧光成像和萤光素酶诱导的生物发光成像。 IC50值表明,使用MDA-MB-231-luc细胞处理24小时后,未靶向和靶向的胶束比Taxotere的效力高出15.31倍和71.73倍。这种胶束的转铁蛋白受体靶向递送在异种移植模型中成像,并显示出它们在实时肿瘤成像和抑制肿瘤生长方面的巨大优势。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号